Skip to main content

MPRIP Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-30716

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-30716

Key Product Details

Species Reactivity

Validated:

Human

Applications

Immunoprecipitation, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Summary for MPRIP Antibody

Immunogen

Between 550 and 600

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for MPRIP Antibody

Application
Recommended Usage

Immunoprecipitation

Optimal dilutions of this antibody should be experimentally determined.

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

Tris-citrate/phosphate pH 7 -8.

Preservative

0.09% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C. Do not freeze.

Background: MPRIP

Alternate Names

KIAA0864Rho interacting protein 3, MRIPP116RIP, myosin phosphatase Rho interacting protein, p116Ripmyosin phosphatase-Rho interacting protein, RHOIP3myosin phosphatase Rho-interacting protein, RIP3M-RIPRho-interacting protein 3

Gene Symbol

MPRIP

Additional MPRIP Products

Product Documents for MPRIP Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for MPRIP Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...